Related references
Note: Only part of the references are listed.The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature
Shengxian Yuan et al.
CLINICAL CANCER RESEARCH (2017)
Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma
Yu Zhang et al.
ONCOLOGY REPORTS (2017)
MicroRNA-302d downregulates TGFBR2 expression and promotes hepatocellular carcinoma growth and invasion
Yue-Liang Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in human Hepatocellular Carcinoma
Naoshi Nishida et al.
LIVER CANCER (2017)
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou et al.
GASTROENTEROLOGY (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Human Hepatocellular Carcinomas With a Periportal Phenotype Have the Lowest Potential for Early Recurrence After Curative Resection
Romain Desert et al.
HEPATOLOGY (2017)
Circular RNA circMTO1 Acts as the Sponge of MicroRNA-9 to Suppress Hepatocellular Carcinoma Progression
Dan Han et al.
HEPATOLOGY (2017)
FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma
Mei-Fang Lin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Jiliang Qiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Global trends and predictions in hepatocellular carcinoma mortality
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2017)
Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)
Hyunsoo Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
Qiuran Xu et al.
MOLECULAR CANCER (2017)
Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway
Xuedong Wang et al.
ONCOLOGY REPORTS (2017)
被撤回的出版物: MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1 (Retracted article. See vol. 49, 2023)
Shiping Hu et al.
ONCOLOGY REPORTS (2017)
MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1
Hui Zhang et al.
ONCOLOGY REPORTS (2017)
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9
Le-yang Xiang et al.
TUMOR BIOLOGY (2017)
MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2)
Yuqiang Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1
Yuanhang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2
Jie Cao et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R. K. Kelley et al.
ANNALS OF ONCOLOGY (2017)
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
Erica Villa et al.
GUT (2016)
Clinicopathological indices to predict hepatocellular carcinoma molecular classification
Poh Seng Tan et al.
LIVER INTERNATIONAL (2016)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4
Changwei Dou et al.
CANCER LETTERS (2016)
Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis
Long-Yun Ye et al.
CANCER RESEARCH (2016)
Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
Emanuela Teveroni et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma
Liyan Wang et al.
FEBS LETTERS (2016)
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
Iris Martinez-Quetglas et al.
GASTROENTEROLOGY (2016)
Oncogenic Driver Genes and the Inflammatory Microenvironment Dictate Liver Tumor Phenotype
Matthias S. Matter et al.
HEPATOLOGY (2016)
miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
Shao-Lai Zhou et al.
HEPATOLOGY (2016)
Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice
Changqing Zhao et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
Hye Won Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinoma
Noriaki Morofuji et al.
CLINICAL PROTEOMICS (2016)
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinoma
Zuzanna Makowska et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy
Jean-Pierre Gillet et al.
MOLECULAR PHARMACOLOGY (2016)
Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications
K. Sartorius et al.
CANCER EPIDEMIOLOGY (2015)
Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin
Jin Song et al.
CANCER LETTERS (2015)
DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma
Augusto Villanueva et al.
HEPATOLOGY (2015)
Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma
Huizhen Nie et al.
HEPATOLOGY (2015)
Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma
Jin-Ping Lai et al.
HISTOPATHOLOGY (2015)
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma
Feng Fang et al.
JOURNAL OF HEPATOLOGY (2015)
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
Oriana Miltiadous et al.
JOURNAL OF HEPATOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
Haiou Liu et al.
NATURE COMMUNICATIONS (2015)
Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis
Evgeniy Stoyanov et al.
ONCOTARGET (2015)
Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma
Huamin Wang et al.
ONCOIMMUNOLOGY (2015)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2014)
Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma
Bryan C. Fuchs et al.
HEPATOLOGY (2014)
c-Myc-Mediated Epigenetic Silencing of MicroRNA-101 Contributes to Dysregulation of Multiple Pathways in Hepatocellular Carcinoma
Lei Wang et al.
HEPATOLOGY (2014)
Modulation of miR-29 Expression by Alpha-Fetoprotein Is Linked to the Hepatocellular Carcinoma Epigenome
Sonya Parpart et al.
HEPATOLOGY (2014)
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF HEPATOLOGY (2014)
Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
Way-Champ Mah et al.
PLOS ONE (2014)
HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators
Sun-Min Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Rongrong Wei et al.
CLINICAL CANCER RESEARCH (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular Carcinoma
Kate Revill et al.
GASTROENTEROLOGY (2013)
Prognostic Gene Expression Signature for Patients With Hepatitis C-Related Early-Stage Cirrhosis
Yujin Hoshida et al.
GASTROENTEROLOGY (2013)
MicroRNA-140-5p Suppresses Tumor Growth and Metastasis by Targeting Transforming Growth Factor β Receptor 1 and Fibroblast Growth Factor 9 in Hepatocellular Carcinoma
Hao Yang et al.
HEPATOLOGY (2013)
MicroRNA-26a Suppresses Tumor Growth and Metastasis of Human Hepatocellular Carcinoma by Targeting Interleukin-6-Stat3 Pathway
Xin Yang et al.
HEPATOLOGY (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Armando Santoro et al.
LANCET ONCOLOGY (2013)
Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection
Biao Deng et al.
ONCOLOGY REPORTS (2013)
Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
Min-Ae Song et al.
PLOS ONE (2013)
Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
Edoardo G. Giannini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Evaluation of the seventh edition of the American Joint Committee on Cancer tumournodemetastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
Albert C. Y. Chan et al.
HPB (2013)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma
Cedric Coulouarn et al.
CANCER RESEARCH (2012)
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways
Cedric Coulouarn et al.
CARCINOGENESIS (2012)
MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma
Priscilla T. -Y. Law et al.
CARCINOGENESIS (2012)
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
Fang Zheng et al.
GUT (2012)
Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma
Naoshi Nishida et al.
HEPATOLOGY (2012)
Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
Zhong-Bo Han et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Yoshito Tomimaru et al.
JOURNAL OF HEPATOLOGY (2012)
MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma
Shupeng Liu et al.
JOURNAL OF HEPATOLOGY (2012)
MicroRNA-550a Acts as a Pro-Metastatic Gene and Directly Targets Cytoplasmic Polyadenylation Element-Binding Protein 4 in Hepatocellular Carcinoma
Qi Tian et al.
PLOS ONE (2012)
MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells
Qing-jun Li et al.
TUMOR BIOLOGY (2012)
Gene Expression Signature of the Gross Morphology in Hepatocellular Carcinoma
Ayano Murakata et al.
ANNALS OF SURGERY (2011)
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
Sara Toffanin et al.
GASTROENTEROLOGY (2011)
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2
Carmen Chak-Lui Wong et al.
GASTROENTEROLOGY (2011)
MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
Dong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Underexpressed microRNA-199b-5p targets Hypoxia-Inducible Factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients
Chuanxi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Gene-expression signature of vascular invasion in hepatocellular carcinoma
Beatriz Minguez et al.
JOURNAL OF HEPATOLOGY (2011)
miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells
Jipeng Li et al.
BMC CANCER (2010)
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
J. Zhang et al.
BRITISH JOURNAL OF CANCER (2010)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
Hyun Goo Woo et al.
CANCER RESEARCH (2010)
Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma
Jongmin Kim et al.
CANCER SCIENCE (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
Fabio Farinati et al.
BMC CANCER (2009)
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
Zhe Zhang et al.
BMC MEDICINE (2009)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
Junfang Ji et al.
HEPATOLOGY (2009)
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
Junfang Ji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
Bryan C. Fuchs et al.
CANCER RESEARCH (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
Jinmai Jiang et al.
CLINICAL CANCER RESEARCH (2008)
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients
Jing-Houng Wang et al.
EUROPEAN JOURNAL OF CANCER (2008)
Proteomic Profiling Reveals the Prognostic Value of Adenomatous Polyposis Coli-End-Binding Protein 1 in Hepatocellular Carcinoma
Tatsuya Orimo et al.
HEPATOLOGY (2008)
Identification of metastasis-related microRNAs in hepatocellular carcinoma
Anuradha Budhu et al.
HEPATOLOGY (2008)
Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score
Hobyung Chung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
Klaus Juergen Schmitz et al.
JOURNAL OF HEPATOLOGY (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F. Fornari et al.
ONCOGENE (2008)
MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma
Heike Varnholt et al.
HEPATOLOGY (2008)
Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma
Sulk Mei Wang et al.
CLINICAL CANCER RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Staging of hepatocellular carcinoma - Assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan
Masami Minagawa et al.
ANNALS OF SURGERY (2007)
Specificity, duplex degradation and subcellular localization of antagomirs
Jan Krutzfeldt et al.
NUCLEIC ACIDS RESEARCH (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: A microarray approach
Ming-Chih Ho et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients
Masahiro Okamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
Pal Kaposi-Novak et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
Y Murakami et al.
ONCOGENE (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Damage to pacemaker lead during mammography
MM Sherman
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic prediction in patients with hepatocellular carcinoma
M Sala et al.
SEMINARS IN LIVER DISEASE (2005)
Resection and liver transplantation for hepatocellular carcinoma
JM Llovet et al.
SEMINARS IN LIVER DISEASE (2005)
Cancer-associated molecular signature in the tissue samples of patients with cirrhosis
JW Kim et al.
HEPATOLOGY (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye et al.
NATURE MEDICINE (2003)
Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection
N Iizuka et al.
LANCET (2003)
Hepatocellular carcinoma - An epidemiologic view
HB El-Serag
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Share Paper
